Panacea Biotec bags order for supply of Oral Polio Vaccine worth Rs 187 crore

17 Dec 2012 Evaluate

Panacea Biotec, India’s second largest producer of vaccines and a highly progressive research based health management company has bagged Government of India’s orders for supply of 345 million doses of Trivalent Oral Polio Vaccines (tOPV) and Bivalent Oral Polio Vaccine (bOPV) worth Rs 187.61 crore.

The order is to be supplied during the period December 2012 till May 2013 to meet the requirements of National Immunisation Days (NIDs) and Supplementary National Immunisation Days (SNIDs).

As per the order, the company will supply 125 million doses of tOPV in the month of December 2012 and 70 million doses of tOPV in the month of January 2013 for the NIDs. Besides, the company will also supply a total of 150 million doses of bOPV to meet the requirements of SNIDs - 100 million doses in the month of February 2013 and 50 million doses in the month of May 2013.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

145.25 1.30 (0.90%)
29-Apr-2024 09:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6277.80
Cipla 1407.20
Zydus Lifesciences 956.00
Lupin 1627.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.